The potential of mRNA vaccines was established during the COVID-19 pandemic. Now, a new wave of candidates could soon hit the ...

A GROUNDBREAKING cancer vaccine could stop tumours growing in patients with advanced disease, researchers say. Designed to ...

The state agency advises people to skip the shot because it doesn’t target the current dominant variant. A USF epidemiologist ...

COVID-19 Positive Rate Spikes With more knowledge about the virus, ample funding, and new treatments, the worst of the ...

Oxford Vaccine Rollout At the very end of December, UK healthcare regulator the Medicines and Healthcare Products Regulatory ...

Did you know that the COVID-19 mRNA vaccination is safe and beneficial for children and adults with sickle cell disease?

Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and ...

The EMA has approved Penbraya for protection against invasive meningococcal disease and an update of the composition of two ...

Researchers at multiple AViDD centers confirm that the NIH has offered a 1-year, no-cost extension, but it doesn’t come with ...

Now, let's get back to our question. Is the stock a buy or a sell? This depends a lot on your own particular investment ...

The following is a summary of “Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials,” published in the September 2024 issue of Infectious Disease by Janes et al.

In light of recent statements by Opposition Leader Kamla Persad-Bissessar and Health Minister Terrence Deyalsingh regarding ...